These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 3876835

  • 21. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
    Buc HA, Thuillier L, Hamet M, Garreau F, Moncion A, Pérignon JL.
    Clin Chim Acta; 1986 Apr 15; 156(1):61-9. PubMed ID: 3486057
    [Abstract] [Full Text] [Related]

  • 22. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
    Smith CM, Henderson JF.
    Biochem Pharmacol; 1982 Apr 15; 31(8):1545-51. PubMed ID: 6980005
    [Abstract] [Full Text] [Related]

  • 23. Purine metabolism in adenosine deaminase deficiency.
    Simmonds HA, Sahota A, Potter CF, Perrett D, Hugh-Jones K, Watson JG.
    Ciba Found Symp; 1978 Apr 15; (68):255-62. PubMed ID: 387357
    [Abstract] [Full Text] [Related]

  • 24. Characterization of adenosine deaminase (ADA)-negative B-lymphoblastoid cells cocultured with ADA-positive fibroblasts.
    Fujita M, Ito K, Kawamoto H, Kashii S, Norioka M, Monden S, Okuma M.
    Eur J Haematol; 1993 Apr 15; 50(4):200-5. PubMed ID: 8500601
    [Abstract] [Full Text] [Related]

  • 25. Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response.
    Ho AD, Ganeshaguru K, Knauf W, Dietz G, Trede I, Hoffbrand AV, Hunstein W.
    Leuk Res; 1989 Apr 15; 13(4):269-78. PubMed ID: 2785618
    [Abstract] [Full Text] [Related]

  • 26. Effect of ADA deficiency on cultured murine thymus transplantation.
    Hong R, Horowitz SD, Fortman C, Martin DW.
    Clin Immunol Immunopathol; 1982 May 15; 23(2):448-58. PubMed ID: 6980759
    [No Abstract] [Full Text] [Related]

  • 27. Reciprocal relationship between erythrocyte ATP and deoxy-ATP levels in inherited ADA deficiency.
    Simmonds HA, Levinsky RJ, Perrett D, Webster DR.
    Biochem Pharmacol; 1982 Mar 15; 31(6):947-51. PubMed ID: 7082375
    [Abstract] [Full Text] [Related]

  • 28. Biochemical and functional abnormalities in lymphocytes from an adenosine deaminase-deficient patient during enzyme replacement therapy.
    Hutton JJ, Wiginton DA, Coleman MS, Fuller SA, Limouze S, Lampkin BC.
    J Clin Invest; 1981 Aug 15; 68(2):413-21. PubMed ID: 7263861
    [Abstract] [Full Text] [Related]

  • 29. Regulation of purine metabolism in lymphocytes.
    Henderson JF, Smith CM, Zombor G.
    Proc Soc Exp Biol Med; 1985 Sep 15; 179(4):419-26. PubMed ID: 3875099
    [Abstract] [Full Text] [Related]

  • 30. Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency.
    Cowan MJ, Shannon KM, Wara DW, Ammann AJ.
    Clin Immunol Immunopathol; 1988 Nov 15; 49(2):242-50. PubMed ID: 2971490
    [Abstract] [Full Text] [Related]

  • 31. In vitro metabolism of deoxycoformycin in human T lymphoblastoid cells. Phosphorylation of deoxycoformycin and incorporation into cellular DNA.
    Siaw MF, Coleman MS.
    J Biol Chem; 1984 Aug 10; 259(15):9426-33. PubMed ID: 6204981
    [Abstract] [Full Text] [Related]

  • 32. Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms.
    Mitchell BS, Kelley WN.
    Ann Intern Med; 1980 Jun 10; 92(6):826-31. PubMed ID: 6247948
    [Abstract] [Full Text] [Related]

  • 33. Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.
    Donofrio J, Coleman MS, Hutton JJ, Daoud A, Lampkin B, Dyminski J.
    J Clin Invest; 1978 Oct 10; 62(4):884-7. PubMed ID: 308954
    [Abstract] [Full Text] [Related]

  • 34. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
    Cohen A, Hirschhorn R, Horowitz SD, Rubinstein A, Polmar SH, Hong R, Martin DW.
    Proc Natl Acad Sci U S A; 1978 Jan 10; 75(1):472-6. PubMed ID: 272665
    [Abstract] [Full Text] [Related]

  • 35. Consequences of adenosine deaminase deficiency on thymocyte metabolism.
    Thuillier L, Garreau F, Cartier PH.
    Eur J Immunol; 1981 Oct 10; 11(10):788-94. PubMed ID: 6975717
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of deoxynucleoside kinases in human thymocytes prevents dATP accumulation and induction of apoptosis.
    Joachims ML, Marble P, Knott-Craig C, Pastuszko P, Blackburn MR, Thompson LF.
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun 10; 27(6):816-20. PubMed ID: 18600545
    [Abstract] [Full Text] [Related]

  • 37. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA, Wasson DB, Lakow E, Kamatani N.
    Proc Natl Acad Sci U S A; 1982 Jun 10; 79(12):3848-52. PubMed ID: 6808516
    [Abstract] [Full Text] [Related]

  • 38. Synergistic effect of 3'-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo.
    Svendsen KR, Overgaard-Hansen K, Frederiksen S.
    Cancer Chemother Pharmacol; 1988 Jun 10; 21(1):35-9. PubMed ID: 3257721
    [Abstract] [Full Text] [Related]

  • 39. Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
    Tanaka M, Kimura K.
    Tohoku J Exp Med; 1985 Dec 10; 147(4):331-41. PubMed ID: 3879563
    [Abstract] [Full Text] [Related]

  • 40. [Immune insufficiency in enzyme defects of purine metabolism].
    Müller G.
    Z Gesamte Inn Med; 1983 Feb 01; 38(3):83-9. PubMed ID: 6303005
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.